We are live on
!
Find out more
MC
Miramar Capital Portfolio holdings
AUM
$449M
1-Year Est. Return
16.73%
This Fund
S&P 500
This Quarter
Est. Return
+10.22%
1 Year Est. Return
+16.73%
3 Year Est. Return
+48.45%
5 Year Est. Return
+65.76%
10 Year Est. Return
–
AUM
$131M
AUM Growth
+$2.99M
(+2.3%)
Cap. Flow
-$116K
Cap. Flow
% of AUM
-0.09%
Top 10 Holdings %
Top 10 Hldgs %
43.46%
Holding
69
New
4
Increased
9
Reduced
40
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$2.05M |
| 2 |
Waste Management
WM
|
+$1.35M |
| 3 |
Home Depot
HD
|
+$1.04M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$200K |
| 5 |
Meta Platforms (Facebook)
META
|
+$191K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.69M |
| 2 |
US Bancorp
USB
|
+$818K |
| 3 |
Sarepta Therapeutics
SRPT
|
+$572K |
| 4 |
Humana
HUM
|
+$237K |
| 5 |
HSBC.PRA
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
|
+$222K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.41% |
| 2 | Technology | 16.29% |
| 3 | Industrials | 13.51% |
| 4 | Consumer Discretionary | 13.43% |
| 5 | Consumer Staples | 11.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Johnson & Johnson
JNJ
$615B
| $6.43M | 4.92% |
45,977
-294
| -0.6% | -$39.4K |
|
2
Apple
AAPL
$4.79T
| $6.27M | 4.8% |
132,084
+20
| +0% | +$848 |
|
3
PepsiCo
PEP
$185B
| $6.22M | 4.76% |
50,764
-385
| -0.8% | -$43.9K |
|
|
RDS.B
4
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $5.74M | 4.39% |
89,735
-155
| -0.2% | -$9.8K |
|
5
Cisco
CSCO
$442B
| $5.66M | 4.33% |
104,815
+590
| +0.6% | +$28.7K |
|
|
6
Home Depot
HD
$330B
| $5.54M | 4.24% |
28,845
+5,691
| +25% | +$1.04M |
|
7
Lockheed Martin
LMT
$119B
| $5.41M | 4.14% |
18,019
-128
| -0.7% | -$37.5K |
|
8
Comcast
CMCSA
$84B
| $5.4M | 4.13% |
135,102
-863
| -0.6% | -$32.5K |
|
9
JPMorgan Chase
JPM
$926B
| $5.17M | 3.96% |
51,064
-270
| -0.5% | -$27.8K |
|
10
Microsoft
MSFT
$2.9T
| $4.96M | 3.8% |
42,052
+390
| +0.9% | +$42.5K |
|
11
Altria Group
MO
$121B
| $4.86M | 3.72% |
84,547
-412
| -0.5% | -$21.1K |
|
12
Merck
MRK
$315B
| $4.2M | 3.21% |
52,873
-1,236
| -2% | -$92.4K |
|
13
Texas Instruments
TXN
$268B
| $4.07M | 3.12% |
38,412
-280
| -0.7% | -$29K |
|
14
Truist Financial
TFC
$63.2B
| $3.89M | 2.98% |
83,690
-2,907
| -3% | -$142K |
|
15
Starbucks
SBUX
$119B
| $3.75M | 2.87% |
50,494
-115
| -0.2% | -$7.9K |
|
16
Amgen
AMGN
$198B
| $3.62M | 2.77% |
19,050
-68
| -0.4% | -$13K |
|
17
McDonald's
MCD
$187B
| $3.54M | 2.71% |
18,665
-20
| -0.1% | -$3.63K |
|
|
18
Medtronic
MDT
$105B
| $3.53M | 2.7% |
38,755
+22,908
| +145% | +$2.05M |
|
19
Genuine Parts
GPC
$16.6B
| $3.45M | 2.64% |
30,792
-50
| -0.2% | -$5.17K |
|
20
Constellation Brands
STZ
$22.6B
| $3.42M | 2.62% |
19,517
+587
| +3% | +$98.9K |
|
21
AbbVie
ABBV
$448B
| $3.3M | 2.53% |
40,970
+95
| +0.2% | +$7.77K |
|
22
3M
MMM
$88.1B
| $3.28M | 2.51% |
18,905
-164
| -0.9% | -$27.6K |
|
23
United Parcel Service
UPS
$98.5B
| $3.27M | 2.5% |
29,254
-91
| -0.3% | -$9.65K |
|
24
CVS Health
CVS
$138B
| $3.21M | 2.45% |
59,471
-270
| -0.5% | -$16.7K |
|
25
Boeing
BA
$164B
| $3.2M | 2.45% |
8,393
+55
| +0.7% | +$21.2K |
|
Similar funds
NL
EGA
OL
PBF
WAS
RMAM
POEH
SMI
Miramar Capital's Q1 2019 Portfolio in Review
As of Q1 2019, Miramar Capital held 69 positions worth $131M, up 2.3% from $128M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Miramar Capital's Q1 2019 filing shows 4 new, 9 increased, 40 reduced and 5 closed positions. Its largest new stake was Waste Management: 13,822 shares worth $1.44M. The largest sale was Pfizer, an estimated $1.69M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.
- Miramar Capital's largest Q1 2019 buy was Waste Management: 13,822 shares worth $1.44M.
- Miramar Capital added most to Medtronic in Q1 2019, an estimated $2.05M increase.
- Miramar Capital's biggest Q1 2019 reduction was Pfizer, cutting an estimated $1.69M.
- Miramar Capital fully exited Sarepta Therapeutics in Q1 2019, selling an estimated $572K.
- Miramar Capital's ten largest holdings make up 43% of its $131M portfolio in Q1 2019.
- Miramar Capital opened 4 new positions and closed 5 in Q1 2019.
- Miramar Capital's portfolio value rose 2.3% quarter-over-quarter to $131M.
Based on Miramar Capital's 13F filing for Q1 2019, filed 13 May 2019.